News

Novo Nordisk has reported new real-world data suggesting that adults with type 2 diabetes who increased their once-weekly semaglutide injection dose from 1 mg to 2 mg had a lower risk…
Read More...

Novo Nordisk has entered into a licensing agreement with Hengrui Pharma for HRS-1596, a Phase 1-ready oral drug candidate that targets both GLP-1 and GIP receptors. Under the…
Read More...

AbbVie has received U.S. Food and Drug Administration (FDA) approval for JUVMO (tavapadon), a once-daily oral treatment for adults with Parkinson’s disease. The approval makes JUVMO the…
Read More...

Tolerance Bio has entered into an exclusive licensing agreement with Tanabe Pharma Corporation to develop and commercialize TLB-33, a clinical-stage anti-IL-33 monoclonal antibody,…
Read More...

Daiichi Sankyo and MSD have voluntarily withdrawn their U.S. Biologics License Application (BLA) for ifinatamab deruxtecan in adults with extensive-stage small cell lung cancer…
Read More...

TriSalus Life Sciences has received U.S. Food and Drug Administration (FDA) 510(k) clearance for TriNav Advance, a new device designed to expand pressure-enabled drug delivery options…
Read More...

Turbine and Daiichi Sankyo have expanded their collaboration to use virtual biology and computational experiments to support the discovery and development of antibody-drug conjugates…
Read More...

Genialis and Inventia Life Science have announced a collaboration aimed at improving how new pancreatic cancer treatments are tested and matched to patients who may benefit from them.…
Read More...

Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin for adults with type 2 diabetes.…
Read More...

Boehringer Ingelheim and the WHO Foundation have launched a three-year collaboration to strengthen obesity care and metabolic health services in resource-limited settings. Under the…
Read More...

Enveda has raised $311 million in a Series E financing round to advance its pipeline of medicines discovered using artificial intelligence and natural biological chemistry. The…
Read More...

Boehringer Ingelheim has partnered with AWARE Germany e.V. and AWARE Trust Zimbabwe to expand rabies prevention efforts in Tsholotsho District, one of Zimbabwe’s remote rural areas.…
Read More...

Basecamp Research has raised $140 million in a Series C financing round to develop its artificial intelligence platform and advance a pipeline of AI-designed medicines toward clinical…
Read More...

Novo Nordisk and UNICEF have expanded their global partnership to prevent childhood overweight and obesity, with a new four-year program expected to reach more than 80 million children.…
Read More...

Boomray Pharmaceuticals has entered into an exclusive global licensing agreement with Novartis for a preclinical radioligand therapy (RLT) asset being developed for precision oncology.…
Read More...

Made Scientific has acquired an 85,000-square-foot cell therapy manufacturing facility in East Norriton, Pennsylvania, from National Resilience as it expands its capacity to support…
Read More...

Merck’s KEYTRUDA QLEX has been approved in Japan for subcutaneous use across all indications currently approved for KEYTRUDA, giving patients another way to receive the cancer…
Read More...

Eli Lilly and Company has broken ground on a new $6.5 billion pharmaceutical manufacturing site in Houston, Texas, as the company expands its U.S. production capacity for medicines.…
Read More...

Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a deal valued at $1.65 billion, bringing together two companies with expertise in radiopharmaceutical…
Read More...

Roche has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for Ocrevus (ocrelizumab) in children and…
Read More...